HARDCASTLE; Ian Robert
Patent Applications and Registrations
Patent applications and USPTO patent grants for HARDCASTLE; Ian Robert.The latest application filed is for "isoindolinone inhibitors of the mdm2-p53 interaction having anticancer activity".
- HARDCASTLE; Ian Robert - Hexham GB
- HARDCASTLE; Ian Robert - Newcastle upon Tyne GB
- - Hexham GB
- Hardcastle; Ian Robert - Tyne GB
- Hardcastle; Ian Robert - Tyne and Wear GB
| Patent | Date |
|---|---|
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20220106287 - CHESSARI; Gianni ; et al. | 2022-04-07 |
| Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 11,261,171 - Chessari , et al. March 1, 2 | 2022-03-01 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20210276984 - CHESSARI; Gianni ; et al. | 2021-09-09 |
| Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,981,898 - Chessari , et al. April 20, 2 | 2021-04-20 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200247789 - Kind Code | 2020-08-06 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20200079761 - CHESSARI; Gianni ; et al. | 2020-03-12 |
| Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity Grant 10,544,132 - Chessari , et al. Ja | 2020-01-28 |
| Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity Grant 10,526,311 - Chessari , et al. J | 2020-01-07 |
| Therapeutic agents Grant 10,414,726 - Golding , et al. Sept | 2019-09-17 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190055215 - CHESSARI; Gianni ; et al. | 2019-02-21 |
| Isoindolinone Inhibitors Of The Mdm2-p53 Interaction Having Anticancer Activity App 20190016708 - CHESSARI; Gianni ; et al. | 2019-01-17 |
| Therapeutic Agents App 20180118684 - GOLDING; Bernard Thomas ; et al. | 2018-05-03 |
| Therapeutic Agents App 20160355478 - GOLDING; Bernard Thomas ; et al. | 2016-12-08 |
| Therapeutic agents Grant 9,358,222 - Golding , et al. June 7, 2 | 2016-06-07 |
| Therapeutic Agents App 20140194486 - GOLDING; Bernard Thomas ; et al. | 2014-07-10 |
| Therapeutic agents Grant 8,618,158 - Golding , et al. December 31, 2 | 2013-12-31 |
| Therapeutic agents Grant 08618158 - | 2013-12-31 |
| Isoindolin-1-one derivatives Grant 8,258,175 - Willems , et al. September 4, 2 | 2012-09-04 |
| Dna-pk Inhibitors App 20110130386 - Frigerio; Mark ; et al. | 2011-06-02 |
| DNA-PK inhibitors Grant 7,732,483 - Smith , et al. June 8, 2 | 2010-06-08 |
| DNA-PK inhibitors Grant 7,696,203 - Smith , et al. April 13, 2 | 2010-04-13 |
| DNA-PK inhibitors Grant 7,674,823 - Martin , et al. March 9, 2 | 2010-03-09 |
| Synthesis Of 2-amino-substituted 4-oxo-4h-chromen-8.yl-trifluoro-methanesulfonic Acid Esters App 20090326223 - Griffin; Roger John ; et al. | 2009-12-31 |
| Isoindolin-1-One Derivatives App 20080261917 - Willems; Hendrika Maria Gerarda ; et al. | 2008-10-23 |
| Dna-pk Inhibitors App 20080242664 - Smith; Graeme Cameron Murray ; et al. | 2008-10-02 |
| DNA-PK inhibitors Grant 7,402,607 - Smith , et al. July 22, 2 | 2008-07-22 |
| Dna-Pk Inhibitors App 20070238731 - Smith; Graeme Cameron Murray ; et al. | 2007-10-11 |
| Dna-pk Inhibitors App 20070238729 - Martin; Niall Morrison Barr ; et al. | 2007-10-11 |
| DNA-PK inhibitors Grant 7,226,918 - Martin , et al. June 5, 2 | 2007-06-05 |
| DNA-PK inhibitors App 20060264623 - Smith; Graeme Cameron Murray ; et al. | 2006-11-23 |
| DNA-PK inhibitors App 20060264427 - Smith; Graeme Cameron Murray ; et al. | 2006-11-23 |
| Thiopyrane-4-ones as DNA protein kinase inhibitors Grant 7,105,518 - Martin , et al. September 12, 2 | 2006-09-12 |
| DNA-PK inhibitors App 20060106025 - Smith; Graeme Cameron Murray ; et al. | 2006-05-18 |
| Thiopyrane-4-ones as dna protein kinase inhibitors App 20050107367 - Martin, Niall Morrison Barr ; et al. | 2005-05-19 |
| Dna-pk inhibitors App 20040192687 - Martin, Niall Morrison Barr ; et al. | 2004-09-30 |
| Cyclin dependent kinase inhibiting purine derivatives App 20040110775 - Griffin, Roger John ; et al. | 2004-06-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 